Galvus Review Delayed For Safety Analysis Of Primate Skin Data

FDA pushes the user fee for the DPP-4 inhibitor back until the end of February.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet